Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbopharm is a specialized life sciences company based in Germany that focuses on carbohydrate chemistry and nucleoside synthesis. The company provides a wide range of high-quality chemical building blocks, including modified sugars, oligosaccharides, and nucleoside analogs, to the pharmaceutical and biotechnology industries. In addition to its extensive product catalog, Carbopharm offers custom synthesis services and contract research to support drug discovery and development projects. Their expertise lies in the complex multi-step synthesis of rare and modified carbohydrates used in various therapeutic and diagnostic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbopharm.